A detailed history of Bare Financial Services, Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Bare Financial Services, Inc holds 203 shares of TGTX stock, worth $6,293. This represents 0.0% of its overall portfolio holdings.

Number of Shares
203
Previous 196 3.57%
Holding current value
$6,293
Previous $7.05 Million 3.96%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$26.39 - $39.19 $184 - $274
7 Added 3.57%
203 $7.33 Million
Q2 2025

Aug 13, 2025

BUY
$33.37 - $45.51 $4,605 - $6,280
138 Added 237.93%
196 $7.05 Million
Q1 2025

May 12, 2025

BUY
$27.67 - $42.99 $1,604 - $2,493
58 New
58 $2.29 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.5B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Bare Financial Services, Inc Portfolio

Follow Bare Financial Services, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bare Financial Services, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bare Financial Services, Inc with notifications on news.